![Toby Ferguson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Toby Ferguson
Corporate Officer/Principal chez
Temple University School of Medicine
Fortune : 748 353 $ au 31/08/2026
Profil
Toby Ferguson is currently an Assistant Professor-Neurology at Temple University School of Medicine.
Formerly, Dr. Ferguson was Chief Medical Officer at Voyager Therapeutics, Inc. from 2024 to 2026 and VP & Head-Neuromuscular Development Unit at Biogen, Inc. from 2020 to 2024.
Education includes a doctorate from the University of Florida College of Medicine and an undergraduate degree from the University of Florida.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/03/2026 | 216 914 ( 0,35 % ) | 748 353 $ | 31/08/2026 |
Postes actifs de Toby Ferguson
| Sociétés | Poste | Début |
|---|---|---|
Temple University School of Medicine
 Temple University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Anciens postes connus de Toby Ferguson
| Sociétés | Poste | Fin |
|---|---|---|
| VOYAGER THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 20/02/2026 |
| BIOGEN INC. | Directeur Technique/Scientifique/R&D | 01/07/2019 |
Formation de Toby Ferguson
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
89
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
University of Florida
 University of Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Voyager Therapeutics, Inc.
 Voyager Therapeutics, Inc. BiotechnologyHealth Technology Develops gene therapies for fatal and debilitating diseases of the central nervous system | Health Technology |
Temple University School of Medicine
Temple University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Florida College of Medicine
 University of Florida College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
